A microbiota-IPA axis facilitates intestinal stem cell-mediated regeneration in colitis through a Hopx-associated program
Top Cited Papers
Open Access
- 25 February 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
The gut microbiota plays a crucial role in maintaining intestinal stem cell (ISC) homeostasis and epithelial barrier integrity. Here, we report that Blautia coccoides (B. coccoides) is significantly reduced in inflammatory bowel disease (IBD) patients and dextran sulfate sodium (DSS)-induced colitis mice. Through an integrated approach combining RNA sequencing, metabolomic profiling, and ISC lineage tracing across multiple mucosal injury models, we demonstrate that B. coccoides colonization enhances β-hydroxybutyrate (BHB) production in intestinal epithelial cells (IECs), which activates HOPX⁺ reserve ISCs and promotes regeneration of the LGR5⁺ ISC pool, thereby accelerating epithelial repair. We further show that B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis. Using an engineered Escherichia coli strain expressing BC-derived phenyllactate dehydrogenase (fldH), we establish that both dietary Trp and bacterial fldH activity are essential for ILA/IPA generation and subsequent mucosal healing. Our findings reveal a microbiota-metabolite-ISC regulatory axis critical for epithelial regeneration and propose novel metabolite-based therapeutic strategies for IBD and other intestinal disorders associated with barrier dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (32172864)
- National Natural Science Foundation of China (8257142928)
- National Natural Science Foundation of China (323B2007)
This publication has 45 references indexed in Scilit:
- Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancerCell, 2024
- Reprogramming of H3K9bhb at regulatory elements is a key feature of fasting in the small intestineCell Reports, 2021
- Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisClinical Gastroenterology and Hepatology, 2020
- Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem CellsCell, 2019
- Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to DietCell, 2019
- Gut Microbiota Regulation of Tryptophan Metabolism in Health and DiseaseCell Host & Microbe, 2018
- The Colonic Crypt Protects Stem Cells from Microbiota-Derived MetabolitesCell, 2016
- Sex Differences in Experimentally Induced Colitis in Mice: a Role for EstrogensInflammation, 2015
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor SuppressorCell, 2012
- Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor ActivationCell, 2011